GDF15 and stage 5 chronic kidney disease: Laučytė-Cibulskienė et al.[17] observed that in 151 male patients with end-stage renal disease, serum levels of GFD-15 were significantly associated with CACS, and those with CACS above 400 had significantly higher GDF-15 concentrations than those with CACS below 400.